ID   PORED_HUMAN             Reviewed;         318 AA.
AC   Q9H8P0; Q4W5Q6;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 134.
DE   RecName: Full=Polyprenol reductase;
DE            EC=1.3.1.94;
DE   AltName: Full=3-oxo-5-alpha-steroid 4-dehydrogenase 3;
DE            EC=1.3.1.22;
DE   AltName: Full=Steroid 5-alpha-reductase 2-like;
DE   AltName: Full=Steroid 5-alpha-reductase 3;
DE            Short=S5AR 3;
DE            Short=SR type 3;
GN   Name=SRD5A3; Synonyms=SRD5A2L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   HIS-296.
RX   PubMed=17986282; DOI=10.1111/j.1349-7006.2007.00656.x;
RA   Uemura M., Tamura K., Chung S., Honma S., Okuyama A., Nakamura Y.,
RA   Nakagawa H.;
RT   "Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in
RT   hormone-refractory prostate cancer.";
RL   Cancer Sci. 99:81-86(2008).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBCELLULAR LOCATION,
RP   INVOLVEMENT IN CDG1Q, AND MUTAGENESIS OF HIS-296.
RX   PubMed=20637498; DOI=10.1016/j.cell.2010.06.001;
RA   Cantagrel V., Lefeber D.J., Ng B.G., Guan Z., Silhavy J.L.,
RA   Bielas S.L., Lehle L., Hombauer H., Adamowicz M., Swiezewska E.,
RA   De Brouwer A.P., Blumel P., Sykut-Cegielska J., Houliston S.,
RA   Swistun D., Ali B.R., Dobyns W.B., Babovic-Vuksanovic D.,
RA   van Bokhoven H., Wevers R.A., Raetz C.R., Freeze H.H., Morava E.,
RA   Al-Gazali L., Gleeson J.G.;
RT   "SRD5A3 is required for converting polyprenol to dolichol and is
RT   mutated in a congenital glycosylation disorder.";
RL   Cell 142:203-217(2010).
RN   [8]
RP   INVOLVEMENT IN KHRZ.
RX   PubMed=20700148; DOI=10.1038/ejhg.2010.132;
RA   Kahrizi K., Hu C.H., Garshasbi M., Abedini S.S., Ghadami S.,
RA   Kariminejad R., Ullmann R., Chen W., Ropers H.H., Kuss A.W.,
RA   Najmabadi H., Tzschach A.;
RT   "Next generation sequencing in a family with autosomal recessive
RT   Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift
RT   mutation in SRD5A3.";
RL   Eur. J. Hum. Genet. 19:115-117(2011).
RN   [9]
RP   INVOLVEMENT IN CDG1Q.
RX   PubMed=22240719; DOI=10.1016/j.ejpn.2011.12.011;
RA   Kasapkara C.S., Tumer L., Ezgu F.S., Hasanoglu A., Race V.,
RA   Matthijs G., Jaeken J.;
RT   "SRD5A3-CDG: A patient with a novel mutation.";
RL   Eur. J. Paediatr. Neurol. 16:554-556(2012).
CC   -!- FUNCTION: Plays a key role in early steps of protein N-linked
CC       glycosylation by being required for the conversion of polyprenol
CC       into dolichol. Dolichols are required for the synthesis of
CC       dolichol-linked monosaccharides and the oligosaccharide precursor
CC       used for N-glycosylation. Acts as a polyprenol reductase that
CC       promotes the reduction of the alpha-isoprene unit of polyprenols
CC       into dolichols in a NADP-dependent mechanism. Also able to convert
CC       testosterone (T) into 5-alpha-dihydrotestosterone (DHT).
CC       {ECO:0000269|PubMed:17986282, ECO:0000269|PubMed:20637498}.
CC   -!- CATALYTIC ACTIVITY: Ditrans,polycis-dolichol + NADP(+) =
CC       ditrans,polycis-polyprenol + NADPH.
CC   -!- CATALYTIC ACTIVITY: A 3-oxo-5-alpha-steroid + NADP(+) = a 3-oxo-
CC       Delta(4)-steroid + NADPH.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:20637498}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305|PubMed:20637498}; Multi-pass membrane protein
CC       {ECO:0000305|PubMed:20637498}.
CC   -!- TISSUE SPECIFICITY: Overexpressed in hormone-refractory prostate
CC       cancers (HRPC). Almost no or little expression in normal adult
CC       organs. {ECO:0000269|PubMed:17986282}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1Q (CDG1Q)
CC       [MIM:612379]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:20637498,
CC       ECO:0000269|PubMed:22240719}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Kahrizi syndrome (KHRZ) [MIM:612713]: An autosomal
CC       recessive neurodevelopmental disorder characterized by mental
CC       retardation, cataracts, coloboma, kyphosis, and coarse facial
CC       features. {ECO:0000269|PubMed:20700148}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the steroid 5-alpha reductase family.
CC       Polyprenol reductase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK023414; BAB14568.1; -; mRNA.
DR   EMBL; CR457312; CAG33593.1; -; mRNA.
DR   EMBL; AC064824; AAY40904.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05465.1; -; Genomic_DNA.
DR   EMBL; BC002480; AAH02480.1; -; mRNA.
DR   CCDS; CCDS3498.1; -.
DR   RefSeq; NP_078868.1; NM_024592.4.
DR   UniGene; Hs.39311; -.
DR   ProteinModelPortal; Q9H8P0; -.
DR   BioGrid; 122772; 3.
DR   IntAct; Q9H8P0; 2.
DR   STRING; 9606.ENSP00000264228; -.
DR   ChEMBL; CHEMBL2363075; -.
DR   DrugBank; DB00421; Spironolactone.
DR   SwissLipids; SLP:000001637; -.
DR   iPTMnet; Q9H8P0; -.
DR   PhosphoSitePlus; Q9H8P0; -.
DR   BioMuta; SRD5A3; -.
DR   DMDM; 74733864; -.
DR   MaxQB; Q9H8P0; -.
DR   PaxDb; Q9H8P0; -.
DR   PeptideAtlas; Q9H8P0; -.
DR   PRIDE; Q9H8P0; -.
DR   DNASU; 79644; -.
DR   Ensembl; ENST00000264228; ENSP00000264228; ENSG00000128039.
DR   GeneID; 79644; -.
DR   KEGG; hsa:79644; -.
DR   UCSC; uc003hau.4; human.
DR   CTD; 79644; -.
DR   DisGeNET; 79644; -.
DR   GeneCards; SRD5A3; -.
DR   GeneReviews; SRD5A3; -.
DR   HGNC; HGNC:25812; SRD5A3.
DR   HPA; HPA027006; -.
DR   MalaCards; SRD5A3; -.
DR   MIM; 611715; gene.
DR   MIM; 612379; phenotype.
DR   MIM; 612713; phenotype.
DR   neXtProt; NX_Q9H8P0; -.
DR   OpenTargets; ENSG00000128039; -.
DR   Orphanet; 324737; SRD5A3-CDG.
DR   PharmGKB; PA162404779; -.
DR   eggNOG; KOG1640; Eukaryota.
DR   eggNOG; ENOG4111JQM; LUCA.
DR   GeneTree; ENSGT00500000044920; -.
DR   HOVERGEN; HBG057797; -.
DR   InParanoid; Q9H8P0; -.
DR   KO; K12345; -.
DR   OMA; VLMQARW; -.
DR   OrthoDB; EOG091G0F09; -.
DR   PhylomeDB; Q9H8P0; -.
DR   TreeFam; TF315011; -.
DR   BioCyc; MetaCyc:HS13249-MONOMER; -.
DR   BRENDA; 1.3.1.22; 2681.
DR   BRENDA; 1.3.1.94; 2681.
DR   Reactome; R-HSA-193048; Androgen biosynthesis.
DR   Reactome; R-HSA-446199; Synthesis of Dolichyl-phosphate.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; SRD5A3; human.
DR   GeneWiki; SRD5A3; -.
DR   GenomeRNAi; 79644; -.
DR   PRO; PR:Q9H8P0; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000128039; -.
DR   CleanEx; HS_SRD5A3; -.
DR   ExpressionAtlas; Q9H8P0; baseline and differential.
DR   Genevisible; Q9H8P0; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003865; F:3-oxo-5-alpha-steroid 4-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0047751; F:cholestenone 5-alpha-reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016628; F:oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; IDA:UniProtKB.
DR   GO; GO:0006702; P:androgen biosynthetic process; TAS:Reactome.
DR   GO; GO:0019348; P:dolichol metabolic process; IDA:UniProtKB.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0006489; P:dolichyl diphosphate biosynthetic process; TAS:Reactome.
DR   GO; GO:0016095; P:polyprenol catabolic process; IDA:UniProtKB.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR001104; 3-oxo-5_a-steroid_4-DH_C.
DR   Pfam; PF02544; Steroid_dh; 1.
DR   PROSITE; PS50244; S5A_REDUCTASE; 1.
PE   1: Evidence at protein level;
KW   Cataract; Complete proteome; Congenital disorder of glycosylation;
KW   Endoplasmic reticulum; Membrane; Mental retardation; NADP;
KW   Oxidoreductase; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    318       Polyprenol reductase.
FT                                /FTId=PRO_0000317703.
FT   TOPO_DOM      1     11       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     12     34       Helical. {ECO:0000255}.
FT   TOPO_DOM     35     80       Lumenal. {ECO:0000255}.
FT   TRANSMEM     81    101       Helical. {ECO:0000255}.
FT   TOPO_DOM    102    117       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    118    138       Helical. {ECO:0000255}.
FT   TOPO_DOM    139    157       Lumenal. {ECO:0000255}.
FT   TRANSMEM    158    178       Helical. {ECO:0000255}.
FT   TOPO_DOM    179    194       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    195    215       Helical. {ECO:0000255}.
FT   TOPO_DOM    216    260       Lumenal. {ECO:0000255}.
FT   TRANSMEM    261    281       Helical. {ECO:0000255}.
FT   TOPO_DOM    282    318       Cytoplasmic. {ECO:0000255}.
FT   MUTAGEN     296    296       H->A: Loss of function.
FT                                {ECO:0000269|PubMed:17986282,
FT                                ECO:0000269|PubMed:20637498}.
SQ   SEQUENCE   318 AA;  36521 MW;  404C7ECBB4A29E6B CRC64;
     MAPWAEAEHS ALNPLRAVWL TLTAAFLLTL LLQLLPPGLL PGCAIFQDLI RYGKTKCGEP
     SRPAACRAFD VPKRYFSHFY IISVLWNGFL LWCLTQSLFL GAPFPSWLHG LLRILGAAQF
     QGGELALSAF LVLVFLWLHS LRRLFECLYV SVFSNVMIHV VQYCFGLVYY VLVGLTVLSQ
     VPMDGRNAYI TGKNLLMQAR WFHILGMMMF IWSSAHQYKC HVILGNLRKN KAGVVIHCNH
     RIPFGDWFEY VSSPNYLAEL MIYVSMAVTF GFHNLTWWLV VTNVFFNQAL SAFLSHQFYK
     SKFVSYPKHR KAFLPFLF
//
